RDN is a minimally invasive procedure that delivers energy to the nerves leading to the kidneys that help regulate blood pressure. Regulating the nerves may help achieve a sustained reduction in blood pressure1
Find Out More About the Procedure
Find the full description of the European Society of Cardiology (ESC) guidelines for Medtronic renal denervation patients.
WATCH NOW: Prof Michael Boehm, Lead Investigator, presenting the latest results from the SPYRAL HTN-OFF MED trial.
Check out the patient site, where you can learn more about the Blood Pressure Procedure (RDN).
VISIT THE PATIENT WEBSITE
Medtronic Intl. Trading
Route du Molliau 31
Medtronic Intl. Ltd.
49 Changi South Avenue 2
Nasaco Tech Centre
Medtronic USA, Inc.
Doral Corporate Center II
3750 NW 87th Avenue, Suite 700
Miami, FL 33178
SYMPLICITY HTN-2 Investigators, The Lancet. 2010: 376, 1903-9.
© 2017 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. ™* Third-party brands are trademarks of their respective owners. For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.